Atrogi Announces Publication on Advancements in Combatting Obesity and Metabolic Complications
24 mai 2024 03h00 HE
|
Atrogi
STOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces a publication in the Journal of...
UMeWorld Limited Invites Investors to Upcoming Webinar, June 4th at 12PM EST Hosted by CEO Michael Lee to Discuss the Upcoming Acquisition and Relocation
23 mai 2024 08h00 HE
|
UMeWorld Limited
UMeWorld Limited Invites Investors to Upcoming Webinar
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
21 mai 2024 08h00 HE
|
Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
21 mai 2024 07h15 HE
|
SAB Biotherapeutics, Inc.
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
20 mai 2024 07h00 HE
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or “the Company”) AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2...
UMeWorld Announces Strategic Expansion in the U.S. and Forecasts Significant Revenue Growth
16 mai 2024 08h00 HE
|
UMeWorld Limited
HONG KONG, May 16, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTCPK: UMEWF) is pleased to announce a strategic plan for expansion in the United States. Having secured proprietary enzymatic...
Pacific Software Inc. Secures Strategic License Agreement with the University of California for Innovative Technology for Stimulating Collagen Production
15 mai 2024 09h00 HE
|
Pacific Software Inc.
Pacific Software Inc. partners with UCI to launch Dermatrix™, a revolutionary collagen-boosting peptide for cosmetics and wound healing.
Rejuvine Life Sciences Launches Crowdfunding Campaign to Revolutionize Diabetes Management with Science-Backed, Natural Solutions
14 mai 2024 06h00 HE
|
Rejuvine Life Sciences Inc.
MIDDLETOWN, Del., May 14, 2024 (GLOBE NEWSWIRE) -- via IBN -- Rejuvine Life Sciences, dedicated to developing natural healthcare solutions, today announces a crowdfunding campaign to expand their...
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
09 mai 2024 07h00 HE
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund...
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
08 mai 2024 06h00 HE
|
Fractyl Health, Inc.
Fractyl Health to Present at BofA Securities 2024 Health Care Conference